Sort   by:  
 Page size 
UnknownMedical treatment for gastro-entero-pancreatic neuroendocrine tumours.
Not available
S-EPMC4824717 | biostudies-literature
UnknownAre All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice.
Not available
S-EPMC8141840 | biostudies-literature
UnknownEarly Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey.
Not available
S-EPMC5118660 | biostudies-literature
UnknownSecond-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?
Not available
S-EPMC5703389 | biostudies-literature
UnknownNeoadjuvant treatments in triple-negative breast cancer patients: where we are now and where we are going.
Not available
S-EPMC5772398 | biostudies-literature
UnknownThe role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib.
Not available
S-EPMC7205300 | biostudies-literature
UnknownPanitumumab: the evidence for its use in the treatment of metastatic colorectal cancer.
Not available
S-EPMC2963923 | biostudies-literature
UnknownRole of SIRT-3, p-mTOR and HIF-1α in Hepatocellular Carcinoma Patients Affected by Metabolic Dysfunctions and in Chronic Treatment with Metformin.
Not available
S-EPMC6470641 | biostudies-literature
UnknownCXC and CC chemokines as angiogenic modulators in nonhaematological tumors.
Not available
S-EPMC4058128 | biostudies-literature
UnknownProgress of molecular targeted therapies for advanced renal cell carcinoma.
Not available
S-EPMC3777192 | biostudies-literature
Sort   by:  
 Page size